4 Recruiting Follicular Lymphoma Phase 3 Clinical Trials
Active phase 3 studies for follicular lymphoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Follicular Lymphoma studiesPhase 3 Studies for Follicular Lymphoma
🔵 Active, Not Recruiting Phase3
A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.
📍 John Muir Health Clinical Research Center — Concord, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
📍 Duke Cancer Center Clinic 1B/C Onc/Heme ( Site 1307) — Durham, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
📍 Local Institution - 0225 — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study of Reduced Dose Radiation Therapy for People With B-Cell Lymphomas
📍 Memorial Sloan Kettering Basking Ridge (All Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔